MVRBF News and Press, Medivir B From 05/03/19

Medivir AB ( OTC:MVRBF ): Q1 GAAP EPS of -SEK2.30. More news on: Medivir AB (publ), Medivir AB ADR, Earnings news and commentary, Tech stocks news, , Read more ...

HUDDINGE, Sweden , May 3, 2019 /PRNewswire/ --January – March Significant events during the quarter The phase II study of birinapant in combination with Keytruda® in colorectal cancer patients progresses according to plan. A futility analysis is planned to be cond...

HUDDINGE, Sweden , April 29, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR)  today announces the appointment of Magnus Christensen as new CFO of Medivir effective as of 12 August 2019 . He will also join the company's management team. In his role, Magnus will be respo...

HUDDINGE, Sweden , Feb. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) as previously announced, Erik Björk will leave the role as Medivir's CFO. Lotta Ferm will assume the role as interim CFO as of March 1st . Recruitment of a permanent CFO is ongoing. For furth...

Medivir ABB ( OTC:MVRBF ): Q4 GAAP EPS of -SEK4.72. More news on: Medivir ABB, Earnings news and commentary, Tech stocks news, , Read more ...

HUDDINGE, Sweden , Feb. 14, 2019 /PRNewswire/ -- Two new projects into clinic October – December Significant events during the quarter The first patient was dosed in the phase II study with birinapant and Keytruda® as combination therapy in colorectal cancer. ...